Industry News

Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

By Labmedica International staff writers
20 Sep 2023

Image: The global fully automatic electrolyte analyzers market is projected to reach close to USD 0.77 billion by 2032 (Photo courtesy of 123RF)

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple bodily functions such as balancing fluids, transmitting nerve signals, and aiding in muscle contraction and relaxation. Electrolyte analyzers work on the principle of ion-selective electrodes, which can specifically identify certain ions and generate an electrical output corresponding to their concentration. Factors like technological innovations, the rising prevalence of chronic diseases, and the growing demand for point-of-care (POC) testing are driving the growth of the global market for fully automatic electrolyte analyzers. The market was valued at USD 0.44 billion in 2022, and is projected to reach USD 0.77 billion by 2032, registering a CAGR of 5.7% from 2023 to 2032.


These are the latest findings of Allied Market Research (Portland, OR, USA), a full-service market research and business-consulting firm.


Several factors are contributing to the growth of the fully automatic electrolyte analyzers market. Among them are the increasing global demand for POC testing, a growing tendency to adopt fully automatic analyzers, and rising imports of these devices in developing nations. POC testing is gaining traction because it offers quick and precise results right where the patient is, thereby further fueling market growth. However, the steep prices of these automated analyzers are limiting market growth. Despite this, an increased emphasis on preventive healthcare is likely to create new opportunities for market players in the coming years.


On the basis of product type, the integrated segment held the lion's share in 2022, accounting for close to two-thirds of total market revenue. This segment is expected to maintain its leading position and is also projected to grow at the fastest CAGR of 6%, due to increasing preference for integrated over standalone devices. These integrated systems offer quicker processing times and easier data handling because they can be connected to laboratory information systems.


Based on modality, the benchtop segment held the largest share in 2022, accounting for over two-thirds of market revenue. This segment is expected to maintain its dominant position largely due to the extensive range of benchtop models provided by major companies. The portable segment, however, is expected to grow at the fastest CAGR of 6.3% during the forecast period due to the increasing demand for POC testing, which in turn is boosting the demand for portable electrolyte analyzers.


Based on end user, diagnostic centers held the largest market share in 2022, accounting for more than two-fifths of the total revenue. These centers favor automatic analyzers as they allow for quick processing of multiple samples, thereby enabling timely reporting to healthcare professionals. Meanwhile, the hospitals segment is likely to experience the highest CAGR of 6.1% in the forecast period, as rising patient admissions are spurring the adoption of these analyzers in hospital environments.


Based on region, North America led the market in 2022, accounting for nearly two-fifths of the global market revenue and is expected to maintain its dominant position during the forecast period. The North American fully automated electrolyte analyzers market is witnessing notable growth, owing to an increase in the prevalence of chronic diseases such as diabetes and cardiovascular diseases. On the other hand, the Asia-Pacific market is expected to witness the fastest CAGR of 6.5% during the forecast period, owing to an increase in the prevalence of hypertension and rise in adoption of advanced fully automatic electrolyte analyzers in the region.


Related Links:
Allied Market Research 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

05 Dec 2023
PerkinElmer Acquires Covaris to Create Global Life-Sciences and Diagnostics Platform
PerkinElmer has acquired Covaris in a deal that will boost Covaris’ growth potential and expand PerkinElmer’s current life sciences portfolio into the high-growth diagnostics end market.
Read More
15 Nov 2023
Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering
Medix Biochemica, a supplier of critical raw materials to the in vitro diagnostics (IVD) industry, has acquired ViroStat LLC, a provider of infectious disease antibodies and antigens used by IVD manufacturers.?
Read More
14 Nov 2023
RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
RSNA 2023 is all set to offer a vast array of medical imaging industry presentations, product demonstrations, workshops, and symposiums in the Technical Exhibits.
Read More
01 Nov 2023
5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
The advent of 5G technology opens doors to the potential for remote surgeries wherein surgeons could operate from distant locations, receiving near-instantaneous feedback thanks to the technology's speed.
Read More
30 Oct 2023
International Hospital Federation Announces 2023 IHF Award Winners
The International Hospital Federation held its annual Award Ceremony and Gala Dinner on October 26, 2023, to celebrate excellence in hospital and healthcare leadership.
Read More
30 Oct 2023
Global ELISA Analyzers Market Driven by Demand for Technologically Advanced Immunological Tools
The global ELISA analyzers market is projected to grow at an impressive rate from 2024 to 2028, due to the increasing demand for reliable infectious disease tests and the growing need for technologically advanced diagnostic tools.
Read More
30 Oct 2023
Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
Surgeons at the forefront of the use of AI to improve surgical care convened recently to discuss the potential uses and ability of AI to predict adverse events and prevent complications.
Read More
26 Oct 2023
Digital Morphology: What Advances Mean for Modern Laboratories, and Why Continued Innovation Is Imperative
Professor Gina Zini reflects on the key benefits of digital developments, including better quality screening, saved time for busy morphologists, better clinical collaboration, improved training, and sharing expertise with developing countries.
Read More
24 Oct 2023
New WHO Guidelines to Revolutionize AI in Healthcare
The World Health Organization has released a new publication that outlines critical regulatory factors concerning the use of AI in healthcare.
Read More
Copyright © 2000-2025 TradeMed.com. All rights reserved. | Terms And Conditions